Wakefield, MA and Barcelona, Spain (PRWEB) January 30, 2014
There will be presentations during the one-day event focusing on the tranSMART open-source knowledge management platform:
•Michael Braxenthaler, vice president of Industry Relations, The tranSMART Foundation, will give an overview of the progress of and perspectives from The tranSMART Foundation.
•Dave Brown, chief technology officer, BT Life Sciences R&D, will discuss overcoming issues in the deployment of secure translational research environments.
•Robin Munro, director, Translational Sciences, IDBS and Mathew Clifford, business development and technical manager, IDBS, will provide a demonstration of the tranSMART APIs, being developed by Imperial College of London.
“eTRIKS has been a critical partner in the development of the tranSMART platform,” said Braxenthaler. “The goals of The tranSMART Foundation are well aligned with eTRIKS’ as both organizations are dedicated to building collaborative communities to increase the efficiency of translational research. We fully support eTRIKS and its efforts to solve the challenges facing translational research projects today and in the future.”
eTRIKS is a knowledge management and service infrastructure project aimed at development of a software and hardware system capable of the efficient storage and effective analysis of experimental data from studies in man, in animals and in pre-clinical models, maximising the scientific knowledge that can be extracted from such studies. The project’s primary goal is to deliver a knowledge management system for ongoing and future IMI studies that require correlative analysis of both pre-clinical and clinical genome-scale biomarker data (genetics and genomics platforms) in conjunction with medical data from clinical trials. This open-source system will also be available for use outside of projects sponsored by IMI. For more information about the eTRIKS project go to - http://www.etriks.org.
About The tranSMART Foundation
The tranSMART Foundation is a non-profit organization that provides an open-source, cloud-based, data-sharing and analysis platform that enables scientists at universities, disease foundations, pharmaceutical companies, and government agencies around the world to share pre-competitive data in a way that saves money and time in translating research findings into new therapies and diagnostic tools. Founded to steward the tranSMART platform, the Foundation is headquartered in Wakefield, Massachusetts with Centers of Excellence in Ann Arbor, Mich.; London, England; Boston, Mass.; and Amsterdam, Netherlands. The tranSMART Foundation can also be found on the web at http://www.tranSMARTFoundation.org.